Cargando…
The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil
The aim of malignant glioma treatment is to inhibit tumor cell proliferation and induce tumor cell apoptosis. Remifentanil is a clinical anesthetic drug that can activate the N-methyl-D-aspartate (NMDA) receptor. NMDA receptor signaling activates glycogen synthase kinase-3β (GSK-3β). Discovered some...
Autores principales: | Xu, Jing, Xu, Pengjuan, Li, Zhigui, Xiao, Lu, Yang, Zhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275801/ https://www.ncbi.nlm.nih.gov/pubmed/23990403 http://dx.doi.org/10.2478/s11658-013-0102-3 |
Ejemplares similares
-
Aberrant spindle dynamics and cytokinesis in Dictyostelium discoideum cells that lack glycogen synthase kinase 3()
por: Harwood, Adrian J., et al.
Publicado: (2013) -
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa
por: Marchena, Miguel, et al.
Publicado: (2017) -
Role of glycogen synthase kinase 3 beta (GSK3β) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
por: Alao, John P, et al.
Publicado: (2006) -
Polarized Regulation of Glycogen Synthase Kinase-3β Is Important for Glioma Cell Invasion
por: Zou, Qifei, et al.
Publicado: (2013) -
The Potential Role of Glycogen Synthase Kinase-3β in Neuropathy-Induced Apoptosis in Spinal Cord
por: Rashvand, Mina, et al.
Publicado: (2020)